Medtech Convergence Fund

Medtech Convergence Fund is the convergence of advanced materials science, component miniaturization, sensors and software telecommunications and new delivery models is creating the potential for new and disruptive solutions for many of the most significant and costly health challenges. The prospect of investing to transform the healthcare industry becomes the goal of the Medtech Convergence Fund.

Medtech Convergence Fund, established in 2020 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Artificial Intelligence (AI), Health Care, Fitness, Elder Care, Enterprise Software, Software, Financial Services, Venture Capital, Finance, SaaS. Their recent investments include CarePredict, Las Olas Venture Capital, Aspire Health Partners, Alpheus Medical, SV Health Investors. The highest investment round they participated in was $7.6B. Among their most notable exits are CarePredict and Las Olas Venture Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.